Rejected at 2:18 p.m. Oct, 09, 2023 ] by Cameron
Author: salmanumer
Related Note: 1499356681408
Rationale for change

"Maintenance pharmacotherapy: similar to that of open-angle glaucoma (see treatment of open-angle glaucoma for further details)"

both types have same pharmacotherapy
Source: AMBOSS - https://www.amboss.com/us/knowledge/glaucoma/

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
These drugs increase aqueous humor outflow through uveoscleral pathway
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#OME::04_Organ_Systems::08_Neuroscience::04_Special_Senses::03_The_Eye_Eye_Pathologies #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#UWorld::COMLEX::25727 #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::25_Glaucoma_Increase_Outflow_of_Aqueous_Humor #AK_Step2_v12::#SketchyIM::13_Ophthalmology::01_Glaucoma #AK_Step1_v12::$AnKingUpdates::$Errata::v01-v05 #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::21_Glaucoma_drugs::Latanoprost_Bimatoprost #AK_Step1_v12::^Other::^HighYield::1-HighYield !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::08_Neuroscience::04_Special_Senses::03_The_Eye_Eye_Pathologies #PANCE::EENT::Eye #AK_Step2_v12::#AMBOSS::bL0Hwg #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::01_Arachidonic_Acid_Pathways #AK_Step1_v12::$AnKingUpdates::$Errata::v06 #AK_Step1_v12::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::21_Glaucoma_drugs #AK_Step2_v12::#AMBOSS::YL0nwg #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PGF2a_Analogs #AK_Step2_v12::#UWorld::18671 #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors #AK_Step1_v12::#AMBOSS::b3aHS4 #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PGF2a_Analogs::Latanoprost_Bimatoprost #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::01_Vasoactive::03_Prostaglandins,_Prostacyclin,_Bosentan,_PDE5_Inhibitors #AK_Step1_v12::#UWorld::Step::11841